Literature DB >> 29653463

Estimation of glycaemic control in the past month using ratio of glycated albumin to HbA1c.

I Musha1, M Mochizuki2, T Kikuchi1, J Akatsuka1, A Ohtake1, K Kobayashi2, N Kikuchi3, T Kawamura4, I Yokota5, T Urakami6, S Sugihara7, S Amemiya1.   

Abstract

AIMS: To evaluate comprehensively the use of the glycated albumin to HbA1c ratio for estimation of glycaemic control in the previous month.
METHODS: A total of 306 children with Type 1 diabetes mellitus underwent ≥10 simultaneous measurements of glycated albumin and HbA1c . Correlation and concordance rates were examined between HbA1c measurements taken 1 month apart (ΔHbA1c ) and glycated albumin/HbA1c ratio fluctuations were calculated as Z-scores from the cohort value at enrolment of this study cohort (method A) or the percent difference from the individual mean over time (method B).
RESULTS: Fluctuations in glycated albumin/HbA1c ratio (using both methods) were weakly but significantly correlated with ΔHbA1c , whereas concordance rates were significant for glycaemic deterioration but not for glycaemic improvement. Concordance rates were higher using method B than method A.
CONCLUSIONS: The glycated albumin/HbA1c ratio was able to estimate glycaemic deterioration in the previous month, while estimation of glycaemic improvement in the preceding month was limited. Because method B provided a better estimate of recent glycaemic control than method A, the individual mean of several measurements of the glycated albumin/HbA1c ratio over time may also identify individuals with high or low haemoglobin glycation phenotypes in a given population, such as Japanese children with Type 1 diabetes, thereby allowing more effective diabetes management.
© 2018 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29653463     DOI: 10.1111/dme.13640

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  1 in total

1.  Mean glycosylated hemoglobin in children with type 1 diabetes at King Fahad Medical City, Riyadh, Saudi Arabia.

Authors:  Abdulhameed Y Alsaheel; Sulaiman I Alayed; Yazzan M Alotaibi; Aseel A Alfahhad; Othman M Alothman; Hissah F Alnefaie
Journal:  J Family Community Med       Date:  2020-09-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.